[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "IAA HUPO alkylation reagent ALL NCE THE disease EM MS JA pooled sample INITIATIVE FITNESS exclamation SHALL SH PARTICULAR INFRINGE EW AS SILAC BMC ... replicate DJ RAW HANCESTRO OR EXPRESS CID URI PMID mass NOT PRIDE WARRANTIES CT ZFA DIA FOR cleavage agent details DOID OF NT FDR INCLUDING biosample accession number CN XML sample REQUIRES III sex PURPOSE organism part spiked compound depletion age VCF source name_ and _assay name URL USE developmental stage MIAME AC PEPTIDESEQ SP PS TA IS MC data file README BE LI ANY MOD ancestry category TO COULD PO BUT collision energy fraction identifier INFORMATION individual DTT PP file your ROW disease stage instrument EFO PATO NOTE PRIDE:0000659 biological replicate UBERON PATCH LIMITED XL cell type PROTEOMICS ISA HEREIN HTML BRENDA MAJOR CLO TIP MERCHANTABILITY PMCID technical replicate CL DISCLAIMS reduction reagent VK CV RIGHTS RECOMMEND PSI SN MUST ENVO RFC STANDARDS IMPORTANT CF MS:1001251 QY WARRANTY RECOMMENDED MAY SHOULD CPTAC CELL OPTIONAL MINOR source name MT MHC MONDO EBI SRM THAT II REQUIRED fractionation method WILL proteomics data acquisition method IMPLIED dissociation method SDRF TMT organism HF PRM HCD CS TAB MAGE NCBI LC PTM COLUMN SWATH characteristics DDA BTO label IDF ID"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "IAA HUPO alkylation reagent ALL NCE THE disease EM MS JA pooled sample INITIATIVE FITNESS SHALL SH PARTICULAR INFRINGE EW AS SILAC BMC ... DJ RAW HANCESTRO OR EXPRESS CID URI PMID mass NOT PRIDE WARRANTIES CT ZFA DIA FOR cleavage agent details DOID OF NT FDR INCLUDING biosample accession number CN REQUIRES III sex PURPOSE organism part spiked compound depletion age VCF URL USE MIAME AC PEPTIDESEQ PS SP TA IS MC data file README BE LI ANY MOD ancestry category TO COULD PO BUT collision energy fraction identifier INFORMATION individual DTT PP ROW disease stage instrument EFO PATO PRIDE:0000659 biological replicate UBERON PATCH LIMITED XL cell type PROTEOMICS ISA HEREIN HTML BRENDA MAJOR CLO MERCHANTABILITY PMCID technical replicate CL DISCLAIMS reduction reagent VK CV RIGHTS RECOMMEND PSI SN MUST ENVO RFC STANDARDS CF MS:1001251 QY WARRANTY RECOMMENDED MAY SHOULD CELL CPTAC OPTIONAL MINOR MT MHC MONDO EBI SRM THAT II REQUIRED fractionation method WILL proteomics data acquisition method IMPLIED dissociation method SDRF TMT organism HF PRM HCD CS TAB MAGE NCBI LC PTM COLUMN SWATH DDA BTO label IDF"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "UBERON:0001088 UBERON:0000948 APP ALL disease exclamation UBERON:0002113 MONDO:0005105 CL:0000576 HANCESTRO PATO:0000461 lib xenograft DOID CL:0000815 MONDO:0005180 sex UBERON:0001359 CL:0000540 organism part CML UBERON:0000955 depletion age URL PATO:0001340 MONDO:0005301 developmental stage MONDO:0005138 UBERON:0000310 CSF CL:0000233 PDX UBERON:0002107 ancestry category PO UBERON:0000178 UBERON:0001155 individual CL:0000232 MONDO:0005148 enrichment process CL:0000813 NK COVID EFO PATO MONDO:0100096 NSG NOTE UBERON biological replicate CL:0000235 cell type TIP MONDO:0008383 CL:0000623 CL CL:0000625 CL:0000788 CL:0000182 MUST compound IMPORTANT CL:0000084 MAY SHOULD PATO:0000384 CL:0000898 source name CL:0000057 synthetic peptide PATO:0000383 UBERON:0002097 UBERON:0001969 MONDO MONDO:0004975 UBERON:0002048 DSS MONDO:0004946 MONDO:0004989 CL:0000913 MONDO:0005575 CL:0000451 CL:0000787 UBERON:0001977 CL:0000236 SDRF organism PTM NCBI CL:0000066 CL:0000624 disease model ID"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "UBERON:0001088 UBERON:0000948 APP ALL disease UBERON:0002113 MONDO:0005105 CL:0000576 HANCESTRO PATO:0000461 xenograft DOID CL:0000815 MONDO:0005180 sex UBERON:0001359 CL:0000540 organism part CML UBERON:0000955 depletion age URL PATO:0001340 MONDO:0005301 developmental stage MONDO:0005138 UBERON:0000310 CSF CL:0000233 PDX UBERON:0002107 ancestry category PO UBERON:0000178 UBERON:0001155 individual CL:0000232 MONDO:0005148 enrichment process CL:0000813 NK COVID EFO PATO MONDO:0100096 NSG biological replicate UBERON CL:0000235 cell type MONDO:0008383 CL:0000623 CL CL:0000625 CL:0000788 CL:0000182 MUST compound CL:0000084 MAY SHOULD PATO:0000384 CL:0000898 source name CL:0000057 synthetic peptide PATO:0000383 UBERON:0002097 UBERON:0001969 MONDO MONDO:0004975 UBERON:0002048 DSS MONDO:0004946 MONDO:0004989 CL:0000913 MONDO:0005575 CL:0000451 CL:0000787 UBERON:0001977 CL:0000236 SDRF organism PTM NCBI CL:0000066 CL:0000624 disease model ID"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "CHEBI:41774 disease MONDO:0004995 exclamation dose GDPR NCIT:C53556 ethnicity NCIT:C71732 NCIT:C65106 HANCESTRO treatment status pregnancy status medication history NCIT:C62723 NCIT:C18213 alcohol consumption ER III NCIT:C27966 sex NCIT:C16358 NCIT:C14169 NCIT:C15313 organism part NCIT:C53554 age BMI diet MONDO:0002050 HANCESTRO:0006 treatment CHEBI:6801 UO MONDO:0005300 NCIT:C65107 NCIT:C81328 NCIT NCIT:C53555 TNM NCIT:C28077 ancestry category menopausal status NCIT:C65108 CHEBI:28748 individual NCIT:C14174 AJCC MONDO:0005148 CHEBI:27899 body mass index MONDO:0005044 PREFERRED breast cancer subtype NCIT:C4870 disease stage prior treatment EFO NOTE NCIT:C18206 MONDO:0004979 IV PR Ann Arbor stage MONDO:0011122 height NCIT:C14167 NCIT:C28078 smoking status NCIT:C53553 HIPAA ACE compound IMPORTANT TNM staging treatment response Dukes stage NCIT:C81327 time post treatment PD sampling time point NCIT:C14168 NCI NCIT:C27971 NCIT:C15445 MONDO NCIT:C15329 HANCESTRO:0009 secondary condition NCIT:C15262 NCIT:C28054 II NCIT:C28079 NCIT:C18058 HANCESTRO:0005 HANCESTRO:0010 NCIT:C28076 pre-existing condition weight NCIT:C15632 tumor grade SDRF gestational age organism NCIT:C27970 NCIT:C68804 ID"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "CHEBI:41774 disease MONDO:0004995 dose GDPR NCIT:C53556 ethnicity NCIT:C71732 NCIT:C65106 HANCESTRO treatment status pregnancy status medication history NCIT:C62723 NCIT:C18213 alcohol consumption ER III NCIT:C27966 sex NCIT:C16358 NCIT:C14169 NCIT:C15313 organism part NCIT:C53554 age BMI diet MONDO:0002050 HANCESTRO:0006 treatment CHEBI:6801 UO MONDO:0005300 NCIT:C65107 NCIT:C81328 NCIT NCIT:C53555 TNM NCIT:C28077 ancestry category menopausal status NCIT:C65108 CHEBI:28748 individual NCIT:C14174 AJCC MONDO:0005148 CHEBI:27899 body mass index MONDO:0005044 PREFERRED breast cancer subtype NCIT:C4870 disease stage prior treatment EFO NCIT:C18206 MONDO:0004979 IV PR Ann Arbor stage MONDO:0011122 height NCIT:C14167 NCIT:C28078 smoking status NCIT:C53553 HIPAA ACE compound TNM staging treatment response Dukes stage NCIT:C81327 time post treatment PD sampling time point NCIT:C14168 NCI NCIT:C27971 NCIT:C15445 MONDO NCIT:C15329 HANCESTRO:0009 secondary condition NCIT:C15262 NCIT:C28054 II NCIT:C28079 NCIT:C18058 HANCESTRO:0005 HANCESTRO:0010 NCIT:C28076 pre-existing condition weight NCIT:C15632 tumor grade SDRF gestational age organism NCIT:C27970 NCIT:C68804 ID"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "PP sample MRM MS1 scan range UNIMOD:737 MS MT scan window lower limit SCIEX instrument exclamation NOTE TOF file uri SILAC SRM XL MS2 analyzer type ELISA URL fragment mass tolerance proteomexchange accession number ST precursor mass tolerance UNIMOD:21 MSD UNIMOD:4 AC RAW REQUIRED TIP TA MS:1001306 proteomics data acquisition method technical replicate UNIMOD:1 data file MGF KR URI UNIMOD PRIDE RPPA FTP TS MS:1001313 SDRF TMT PRIDE:0000663 PRM HF MOD UNIMOD:35 CS scan window upper limit modification parameters PSI LTQ MS:1001309 MM MUST fraction DIA IMPORTANT cleavage agent details fraction identifier MS:1001917 CF DDA MS:1001251 MS:1001303 NT label RECOMMENDED SHOULD ID"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "PP MRM MS1 scan range UNIMOD:737 MS MT scan window lower limit SCIEX instrument TOF file uri SILAC SRM XL MS2 analyzer type ELISA URL fragment mass tolerance proteomexchange accession number ST precursor mass tolerance UNIMOD:21 MSD UNIMOD:4 AC RAW REQUIRED TA MS:1001306 proteomics data acquisition method technical replicate UNIMOD:1 data file MGF KR URI UNIMOD PRIDE RPPA FTP TS MS:1001313 SDRF TMT PRIDE:0000663 PRM HF MOD UNIMOD:35 CS scan window upper limit modification parameters PSI LTQ MS:1001309 MM MUST DIA cleavage agent details fraction identifier MS:1001917 CF DDA MS:1001251 MS:1001303 NT label RECOMMENDED SHOULD ID"
  }
]